• Title/Summary/Keyword: reproductive medicine

Search Result 3,733, Processing Time 0.024 seconds

Reproductive toxic agents in work environments and related cases in Korea

  • Park, Chulyong
    • Journal of Yeungnam Medical Science
    • /
    • v.37 no.1
    • /
    • pp.22-31
    • /
    • 2020
  • There has been a growing concern and subsequent interest surrounding numerous reproductive toxic agents found in various working and non-working environments. Meanwhile, there have been many efforts in medical fields such as toxicology and epidemiology applying experimental studies to elucidate reproductive toxic agents' characterization and health effects. However, there remains insufficient research data and inadequate evidence in humans. Adverse reproductive outcomes vary from transient, moderate health effects to severely detrimental consequences, such as permanent infertility or childhood cancer of one's offspring. Furthermore, upon exposure to toxic agents, the latent period before reproductive health effects are observed is relatively short compared to other occupational diseases (e.g., occupational cancer); instant action is required once exposure to reproductive toxic agents is detected. Therefore, it is very important for workers and healthcare professionals to know about the reproductive toxic agents they are likely to be exposed to. In this review, we discuss the general epidemiology of reproductive health in Korea, and the information regarding these reproductive toxic agents.

Intravenous immunoglobulin G in women with reproductive failure: The Korean Society for Reproductive Immunology practice guidelines

  • Sung, Nayoung;Han, Ae Ra;Park, Chan Woo;Park, Dong Wook;Park, Joon Cheol;Kim, Na Young;Lim, Kyung Sil;Shin, Ji Eun;Joo, Chang Woo;Lee, Seung Eun;Kim, Jae Won;Lee, Sung Ki;IVIG Task Force Korean Society for Reproductive Immunology
    • Clinical and Experimental Reproductive Medicine
    • /
    • v.44 no.1
    • /
    • pp.1-7
    • /
    • 2017
  • The task force of the Korean Society for Reproductive Immunology recommends intravenous immunoglobulin G treatment in women with reproductive failure, including recurrent pregnancy loss and/or repeated implantation failure, who show cellular immune factors such as abnormal natural killer cell levels, natural killer cell cytotoxicity, and/or type 1 T helper immunity.